An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone who started using a GLP-1 drug (a class that includes semaglutide, the active ingredient in brand names like Ozempic and Wegovy) wrote that they felt fine while slowly increasing their dose, but after jumping from 1 mg to 1.7 mg per week they suddenly found it "too much" — extreme reduction in appetite and energy, a very large calorie deficit, and a sense that their body had hit a limit. They also report substantial weight loss so far (about 13 kg since May) but that the recent higher dose was jarring. Semaglutide is a medicine that mimics a hormone your gut makes after you eat. That hormone tells your brain you’re full and slows how fast your stomach empties, so you eat less and feel satisfied for longer. Doctors prescribe it at different doses for diabetes and for weight management. People typically start low and increase slowly to help the body adapt to changes in appetite, digestion, and energy. The snippet is a first-person account, not a clinical trial. It’s an anecdote from one person describing their experience over a few months as they escalated the dose. They report steady, meaningful weight loss on lower doses and then a sharp change after the jump to 1.7 mg: much stronger appetite suppression and fatigue. Anecdotes like this can illustrate what can happen to some people, but they don’t tell us how common these reactions are or the full range of possible outcomes. Why this matters is practical: if you’re thinking about or already using GLP-1 drugs, dose increases can change how you feel in noticeable ways. For some people that stronger suppression of appetite is welcome because it speeds weight loss; for others it can lead to dangerously low calorie intake, fatigue, dizziness, or trouble functioning. The decision to increase a dose should usually be guided by a clinician who can monitor for adverse effects and adjust the plan if the higher dose is too much. There are important caveats. This is one person’s experience, not proof of how everyone will react. Semaglutide and other GLP-1 drugs can cause side effects like nausea, fatigue, low blood sugar in people on diabetes medicines, and occasional more serious issues; they should be used under medical supervision. People with certain conditions or taking certain medicines may need different care. If appetite drops so far that you can’t meet basic nutritional needs or you feel faint or weak, that’s a signal to contact your healthcare provider about lowering the dose or pausing treatment. Bottom line: some people tolerate gradual increases in GLP-1 drugs well, but a jump in dose can suddenly feel like too much — and any change that leaves you overly weak or undernourished should prompt medical advice.
Source: r/Semaglutide